TrialClinical and experimental immunology2021

The prevalence of anti-neurofascin-155 antibodies in patients with neuromyelitis optica spectrum disorders.

Sheng-Hui Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.